The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs
Open accessAbstract
To prepare immunomicelles, new targeted carriers for poorly soluble pharmaceuticals, a procedure has been developed to chemically attach mAbs to reactive groups incorporated into the corona of polymeric micelles made of polyethylene glycol–phosphatidylethanolamine conjugates. Micelle-attached antibodies retained their ability to specifically interact with their antigens. Immunomicelles with attached antitumor mAb 2C5 effectively recognized and bound various cancer cells in vitro and showed an increased accumulation in experimental tumors in mice when compared with nontargeted micelles. Intravenous administration of tumor-specific 2C5 immunomicelles loaded with a sparingly soluble anticancer agent, taxol, into experimental mice bearing Lewis lung carcinoma resulted in an increased accumulation of taxol in the tumor compared with free taxol or taxol in nontargeted micelles and in enhanced tumor growth inhibition. This family of pharmaceutical carriers can be used for the solubilization and enhanced delivery of poorly soluble drugs to various pathological sites in the body.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Self-citationRegulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Self-citationStructure and design of polymeric surfactant-based drug delivery systems
Torchilin, V. P. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00299-1 · Cited by 1,822
Self-citationVascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Self-citationPolymeric micelles—A new generation of colloidal drug carriers
Jones, M.-C., & Leroux, J.-C. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00039-9 · Cited by 1,256
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,069
Maeda, H., Sawa, T., & Konno, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00309-1 · Cited by 925
Yuan, F., Leunig, M., Huang, S. K., Berk, D. A., Papahadjopoulos, D., & Jain, R. K. (1994) · PubMed · Cited by 908
Block copolymer micelles as long-circulating drug vehicles
Kwon, G. S., & Kataoka, K. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00031-2 · Cited by 823
Torchilin, V. P., Rammohan, R., Weissig, V., & Levchenko, T. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151247498 · Cited by 777
Self-citationFate and behavior of liposomes in vivo: a review of controlling factors.
Senior, J. H. (1987) · PubMed · Cited by 591
Which polymers can make nanoparticulate drug carriers long-circulating?
Torchilin, V. P., & Trubetskoy, V. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00022-y · Cited by 480
Self-citationCrosasso, P., Ceruti, M., Brusa, P., Arpicco, S., Dosio, F., & Cattel, L. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00166-2 · Cited by 338
Tumor targeting using anti-her2 immunoliposomes
Park, J. W., Kirpotin, D. B., Hong, K., Shalaby, R., Shao, Y., Nielsen, U. B., Marks, J. D., Papahadjopoulos, D., & Benz, C. C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00315-7 · Cited by 335
Kabanov, A. V., Chekhonin, V. P., Alakhov, V. Y., Batrakova, E. V., Lebedev, A. S., Melik-Nubarov, N. S., Arzhakov, S. A., Levashov, A. V., Morozov, G. V., Severin, E. S., et al. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81689-8 · Cited by 296
Torchilin, V. P., Levchenko, T. S., Lukyanov, A. N., Khaw, B. A., Klibanov, A. L., Rammohan, R., Samokhin, G. P., & Whiteman, K. R. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2728(01)00165-7 · Cited by 271
Self-citationDiacyllipid-Polymer Micelles as Nanocarriers for Poorly Soluble Anticancer Drugs
Gao, Z., Lukyanov, A. N., Singhal, A., & Torchilin, V. P. (2002) · Nano Letters · doi:10.1021/nl025604a · Cited by 262
Self-citationLiposome circulation time and tumor targeting: implications for cancer chemotherapy
Gabizon, A. A. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00030-b · Cited by 255
Lukyanov, A. N., Gao, Z., Mazzola, L., & Torchilin, V. P. (2002) · Pharmaceutical Research · doi:10.1023/a:1020488012264 · Cited by 227
Self-citationMicroparticulate Systems for the Delivery of Proteins and Vaccines
(2020) · CRC Press eBooks · doi:10.1201/9781003067542 · Cited by 199
Microparticulate systems for the delivery of proteins and vaccines
Lee, G. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00045-3 · Cited by 199
Weissig, V., Whiteman, K. R., & Torchilin, V. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011951016118 · Cited by 170
Self-citationMixed micelles in drug delivery
Lasic, D. D. (1992) · Nature · doi:10.1038/355279a0 · Cited by 162
Muranishi, S. (1990) · PubMed · Cited by 154
Monoclonal Antibody to Cardiac Myosin: Imaging of Experimental Myocardial Infarction
Khaw, B., Mattis, J. A., Melincoff, G. A., Strausś, H. W., Gold, H. K., & Haber, E. (1984) · Hybridoma · doi:10.1089/hyb.1984.3.11 · Cited by 152
Monoclonal antibodies in cancer detection and therapy
Goldenberg, D. M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90062-t · Cited by 148
Trubetskoy, V. S., & Torchilin, V. P. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00032-3 · Cited by 148
Self-citationVinogradov, S. V., Batrakova, E. V., Li, S., & Kabanov, A. V. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990037c · Cited by 143
Parr, M. J., Masin, D., Cullis, P. R., & Bally, M. B. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36521-8 · Cited by 126
A liposomal MRI contrast agent: Phosphatid ylethanolamine‐DTPA
Grant, C. W. M., Karlik, S. J., & Florio, E. (1989) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910110211 · Cited by 102
Hageluken, A., Grünbaum, L., Nürnberg, B., Harhammer, R., Schunack, W. G., & Seifert, R. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90307-7 · Cited by 98
The mechanism of liposome accumulation in infarction
Palmer, T. N., Caride, V. J., Caldecourt, M. A., Twickler, J., & Abdullah, V. S. (1984) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(84)90258-7 · Cited by 95
Torchilin, V. P., Narula, J., Halpern, E. F., & Khaw, B. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00248-0 · Cited by 91
Self-citationIakoubov, L. Z., & Torchilin, V. P. (1997) · PubMed · Cited by 83
Self-citationFernandez, A.-M., derpoorten, K. V., Dasnois, L., Lebtahi, K., Dubois, V., Lobl, T. J., Gangwar, S., Oliyai, C., Lewis, E. R., Shochat, D., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0108754 · Cited by 78
Relationships in the Structure–Tissue Distribution of Basic Drugs in the Rabbit
Yokogawa, K., Nakashima, E., Ishizaki, J., MAEDA, H., Nagano, T., & Ichimura, F. (1990) · Pharmaceutical Research · doi:10.1023/a:1015803202857 · Cited by 69
Monoclonal Antibodies in the Treatment of Malignancy: Basic Concepts and Recent Developments
Dillman, R. O. (2001) · Cancer Investigation · doi:10.1081/cnv-100107745 · Cited by 67
Reversed-phase high-performance liquid chromatographic determination of taxol in mouse plasma
Sharma, A., Conway, W. D., & Straubinger, R. M. (1994) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(94)00117-0 · Cited by 61
Kirshner, R. (1994) · Scientific American · doi:10.1038/scientificamerican1094-58 · Cited by 57
Micellar Delivery System for Dequalinium—A Lipophilic Cationic Drug with Anticarcinoma Activity
Weissig, V., Lizano, C., & Torchilin, V. P. (1998) · Journal of Liposome Research · doi:10.3109/08982109809035542 · Cited by 43
Self-citation
Cited by
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Micellar Nanocarriers: Pharmaceutical Perspectives
Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910
Self-citationAdvanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Metadata
- Authors
- Torchilin, V. P., Lukyanov, A. N., Gao, Z., & Papahadjopoulos-Sternberg, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-04-25
- Volume
- 100
- Issue
- 10
- Pages
- 6039-6044
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2087597184
- Cited by
- 538
- References
- 41
- FWCI
- 12.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.